Shen Zheng-Lei, Yin Lie-Fen, Mao Wen-Wen, Liang Jin, Yang Ling
Department of Hematology, Yunnan Tumor Hospital, Kunming, Yunnan 650118, P.R. China.
Department of Hematology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650031, P.R. China.
Oncol Lett. 2016 Apr;11(4):2909-2912. doi: 10.3892/ol.2016.4304. Epub 2016 Mar 7.
The current study reports the case of a patient with Philadelphia chromosome-negative (Ph) non-Hodgkin's lymphoma (NHL) and chronic phase (CP) Philadelphia chromosome-positive (Ph) chronic myeloid leukemia (CML) that also possessed characteristic enlarged lymph nodes. A lymph node biopsy resulted in the diagnosis of CP-CML, in addition to T-lymphoblastic cell NHL with negative break point cluster/Abelson tyrosine kinase fusion genes in the lymph node of the patient, which was diagnosed as Ph NHL. A review of the literature was performed in the present study to investigate the genetic differences between Ph NHL and Ph NHL in patients with CML. The median age of patients with NHL and CML was 41 years. The follow-up time of patients with Ph NHL was significantly shorter (mean, <6 months) compared to the follow-up time of patients with Ph NHL (mean, >15 months). Therefore the present study concludes that Ph NHL may be more aggressive compared with Ph NHL. The present study suggests that additional studies are required to assess the clinical and genetic characteristics of NHL patients with CML.
本研究报告了一例费城染色体阴性(Ph)非霍奇金淋巴瘤(NHL)合并慢性期(CP)费城染色体阳性(Ph)慢性髓性白血病(CML)的患者,该患者同时伴有特征性肿大淋巴结。淋巴结活检结果除诊断为CP-CML外,患者淋巴结中T淋巴母细胞性NHL的断点簇集区/阿贝尔森酪氨酸激酶融合基因呈阴性,该患者被诊断为Ph NHL。本研究进行了文献回顾,以调查CML患者中Ph NHL与Ph NHL之间的基因差异。NHL和CML患者的中位年龄为41岁。与Ph NHL患者的随访时间(平均>15个月)相比,Ph NHL患者的随访时间明显更短(平均<6个月)。因此,本研究得出结论,与Ph NHL相比,Ph NHL可能更具侵袭性。本研究表明,需要进一步研究以评估CML合并NHL患者的临床和基因特征。